Physician profile
Jay C Jan
NPI 1417949926
$1,659.40
in general payments reported to CMS, 2019-2025
12 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $629 · 2021: $58.36 · 2022: $112 · 2023: $25.70 · 2024: $263 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $870.43 | 2019-2025 | |
| Teleflex LLC | $141.58 | 2025 | Titan Sgs Bailout Chuck |
| Medtronic, INC. | $135.83 | 2024-2025 | Signia, Sonicision |
| Davol INC. | $135.71 | 2021-2022 | |
| Covidien Lp | $105.01 | 2019 | |
| Stryker Corporation | $68.45 | 2024 | 1788 |
| Baxter Healthcare | $62.36 | 2022-2024 | Floseal |
| Ethicon US, LLC | $46.50 | 2019 | |
| Creo Medical INC. | $27.04 | 2024 | Speedboat Ultraslim (Sb1l) |
| Integra Lifesciences Corporation | $25.70 | 2023 | Integra, Surgimend, Omnigraft |
| Boston Scientific Corporation | $21.09 | 2024 | Spyglass Discover |
| Polynovo North America LLC | $19.70 | 2024 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Jan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.